Please assess the completion status of the following clinical trial:

Trial Title: Nucleus Hybrid L24 Extended Duration Post Approval Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~- Recipients who were implanted with the Hybrid L24 as part of the original pivotal IDE study~Exclusion Criteria:~* Recipients who withdrew or were terminated from the L24 pivotal IDE study~* Recipients who were re-implanted and no longer have a Nucleus Hybrid L24 implant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Hybrid L24 pivotal study subjects (Type: EXPERIMENTAL): Subjects implanted with the Nucleus Hybrid L24 Implant as part of the pivotal IDE study and who still have the device implanted will continue to be followed for 5 years post activation

Based on this trial design, predict the completion outcome and termination type (if applicable).